Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice

BioScience Trends

Volumn 5, Issue 3, 2011, Pages 129-138

  Mishra, Manisha ^a,b   Huang, Junjie ^a   Lee, Yin Yeng ^a   Chua, Doreen See Kin ^a   Lin, Xiaoyan ^a   Hu, Jiang Miao ^c   Heese, Klaus ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Amyloid precursor protein; Alzheimer's disease; Kampo; Neurodegeneration; Traditional Chinese medicine

Indexed keywords

GASTRODIA ELATA; MUS;

AMYLOID PRECURSOR PROTEIN; HERBACEOUS AGENT; SECRETASE;

ANIMAL; ARTICLE; CHEMISTRY; COGNITION; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME ACTIVATION; GASTRODIA; METABOLISM; MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; COGNITION; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; GASTRODIA; MICE; NEURODEGENERATIVE DISEASES;

EID: 84863115918     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2011.v5.3.129     Document Type: Article

References (70)

1. Schachter SC. Botanicals and herbs: A traditional approach to treating epilepsy. Neurotherapeutics. 2009; 6:415-420.
2. Sucher NJ. Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy. Epilepsy Behav. 2006; 8:350-362.
3. Yuan R, Lin Y. Traditional Chinese medicine: An approach to scientific proof and clinical validation. Pharmacol Ther. 2000; 86:191-198.
4. Hew CS, Yong JWH. Orchids in Chinese medicine. Innovation. 2006; 6:20-25.
5. Kumari U, Heese K. Cardiovascular dementia - A different perspective. Open Biochem J. 2010; 4:29-52.
6. Heese K, Akatsu H. Alzheimer's disease - An interactive perspective. Curr Alzheimer Res. 2006; 3:109-121.
7. Chen PJ, Hsieh CL, Su KP, Hou YC, Chiang HM, Lin IH, Sheen LY. The antidepressant effect of Gastrodia elata Bl. on the forced-swimming test in rats. Am J Chin Med. 2008; 36:95-106.
8. Ho SC, Ho YF, Lai TH, Liu TH, Su SY, Wu RY. Effect of Tianma Gouteng Decoction with subtractive ingredients and its active constituents on memory acquisition. Am J Chin Med. 2008; 36:593-602.
9. Ho SC, Ho YF, Lai TH, Liu TH, Wu RY. Traditional Chinese herbs against hypertension enhance memory acquisition. Am J Chin Med. 2005; 33:787-795.
10. Teong IWJ, Ko AAR, Li M, Heese K, Liang W. Gastrodia elata decreases isoprenaline potency and enhances spontaneous phasic activity in the rat detrusor. Int J Physiol Pathophysiol Pharmacol. 2011; 3:29-37.
11. Li N, Wang KJ, Chen JJ, Zhou J. Phenolic compounds from the rhizomes of Gastrodia elata. J Asian Nat Prod Res. 2007; 9:373-377.
12. +-induced cytotoxicity in human dopaminergic SH-SY5Y cells. J Ethnopharmacol. 2010; 130:290-298.
13. Huang NK, Lin YL, Cheng JJ, Lai WL. Gastrodia elata prevents rat pheochromocytoma cells from serumdeprived apoptosis: The role of the MAPK family. Life Sci. 2004; 75:1649-1657.
14. Sim PL, Heese K. Ligand-dependent activation of the chimeric tumor necrosis factor receptor-amyloid precursor protein (APP) reveals increased APP processing and suppressed neuronal differentiation. Neurosignals. 2010; 18:9-23.
15. Islam O, Loo TX, Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res. 2009; 6:42-53.
16. Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protoc. 2006; 1:1671-1679.
17. Carlini VP, Martini AC, Schioth HB, Ruiz RD, Fiol de Cuneo M, de Barioglio SR. Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration. Neuroscience. 2008; 153:929-934.
18. Lebrun C, Pilliere E, Lestage P. Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats. Eur J Pharmacol. 2000; 401:205-212.
19. Ennaceur A. One-trial object recognition in rats and mice: Methodological and theoretical issues. Behav Brain Res. 2010; 215:244-254.
20. Houston-Price C, Nakai S. Distinguishing novelty and familiarity effects in infant preference procedures. Infant Child Dev. 2004; 13:341-348.
21. Roder B, Bushnell E, Sasseville AM. Infants' preferences for familiarity and novelty during the course of visual processing. Infancy. 2000; 1:491-508.
22. Ennaceur A, Michalikova S, Bradford A, Ahmed S. Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav Brain Res. 2005; 159:247-266.
23. Selkoe DJ, Schenk D. Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003; 43:545-584.
24. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004; 430:631-639.
25. Peng Y, Jiang L, Lee DY, Schachter SC, Ma Z, Lemere CA. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells. J Neurosci Res. 2006; 84:903-911.
26. Peng Y, Lee DY, Jiang L, Ma Z, Schachter SC, Lemere CA. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Neuroscience. 2007; 150:386-395.
27. Zhang HY, Tang XC. Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease. Trends Pharmacol Sci. 2006; 27:619-625.
28. Wang R, Tang XC. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals. 2005; 14:71-82.
29. Kim DS, Kim JY, Han YS. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from betaamyloid (1-42) insult. J Altern Complement Med. 2007; 13:333-340.
30. Huang NK, Chern Y, Fang JM, Lin CI, Chen WP, Lin YL. Neuroprotective principles from Gastrodia elata. J Nat Prod. 2007; 70:571-574.
31. Bulpitt CJ, Li Y, Bulpitt PF, Wang J. The use of orchids in Chinese medicine. J R Soc Med. 2007; 100:558-563.
32. Hsieh MT, Wu CR, Chen CF. Gastrodin and p-hydroxybenzyl alcoholfacilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol. 1997; 56:45-54.
33. Kim HJ, Moon KD, Oh SY, Kim SP, Lee SR. Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acidinduced neuronal damage in the mouse hippocampus. Neurosci Lett. 2001; 314:65-68.
34. Kim HJ, Moon KD, Lee DS, Lee SH. Ethyl ether fraction of Gastrodia elata Blume protects amyloid beta peptideinduced cell death. J Ethnopharmacol. 2003; 84:95-98.
35. Kim HJ, Lee SR, Moon KD. Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytother Res. 2003; 17:909-912.
36. Ong ES, Heng MY, Tan SN, Hong Yong JW, Koh H, Teo CC, Hew CS. Determination of gastrodin and vanillyl alcohol in Gastrodia elata Blume by pressurized liquid extraction at room temperature. J Sep Sci. 2007; 30:2130-2137.
37. Hsieh CL, Chiang SY, Cheng KS, Lin YH, Tang NY, Lee CJ, Pon CZ, Hsieh CT. Anticonvulsive and free radical scavenging activities of Gastrodia elata Bl. in kainic acid-treated rats. Am J Chin Med. 2001; 29:331-341.
38. Kim ST, Kim JD, Lyu YS, Lee MY, Kang HW. Neuroprotective effect of some plant extracts in cultured CT105-induced PC12 cells. Biol Pharm Bull. 2006; 29:2021-2024.
39. Zhou BH, Li XJ, Liu M, Wu Z, Ming Hu X. Antidepressant-like activity of the Gastrodia elata ethanol extract in mice. Fitoterapia. 2006; 77:592-594.
40. Chen PJ, Hsieh CL, Su KP, Hou YC, Chiang HM, Sheen LY. Rhizomes of Gastrodia elata B(L) possess antidepressant-like effect via monoamine modulation in subchronic animal model. Am J Chin Med. 2009; 37:1113-1124.
41. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology. 2004; 63:1181-1186.
42. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: A review. Brain Res Rev. 2007; 56:384-402.
43. Hulette CM, Welsh-Bohmer K. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology. 2007; 68:471.
44. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: A population-based cohort study. Arch Intern Med. 2006; 166:1003-1008.
45. Zhu W, Hu H. A survey of TCM treatment for Alzheimer's disease. J Tradit Chin Med. 2007; 27:226-232.
46. Hadjiev D, Mineva P. Antihypertensive treatment in reducing the risk of dementia. Stroke. 2006; 37:2869.
47. Bergmann C, Sano M. Cardiac risk factors and potential treatments in Alzheimer's disease. Neurol Res. 2006; 28:595-604.
48. de la Torre JC. How do heart disease and stroke become risk factors for Alzheimer's disease? Neurol Res. 2006; 28:637-644.
49. Polidori MC, Mariani E, Mecocci P, Nelles G. Congestive heart failure and Alzheimer's disease. Neurol Res. 2006; 28:588-594.
50. Wolozin B, Bednar MM. Interventions for heart disease and their effects on Alzheimer's disease. Neurol Res. 2006; 28:630-636.
51. Kimberly WT, Zheng JB, Town T, Flavell RA, Selkoe DJ. Physiological regulation of the beta-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation. J Neurosci. 2005; 25:5533-5543.
52. Protecting hearts, saving minds? Cause and effect are hard to prove but research suggests that taking care of your heart may help protect your brain. Harv Health Lett. 2007; 32:5.
53. Zhang HY, Zheng CY, Yan H, Wang ZF, Tang LL, Gao X, Tang XC. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. Chem Biol Interact. 2008; 175:396-402.
54. Zangara A. The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav. 2003; 75:675-686.
55. Houghton PJ, Howes MJ. Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. Neurosignals. 2005; 14:6-22.
56. Howes MJ, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav. 2003; 75:513-527.
57. Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res. 2003; 17:1-18.
58. Suk K. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids. Neurosignals. 2005; 14:23-33.
59. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005; 14:34-45.
60. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, irondependent oxidative stress and PKC signaling pathway. Neurosignals. 2005; 14:46-60.
61. Dore S. Unique properties of polyphenol stilbenes in the brain: More than direct antioxidant actions; gene/protein regulatory activity. Neurosignals. 2005; 14:61-70.
62. Wang ZF, Wang J, Zhang HY, Tang XC. Huperzine A exhibits anti-inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia. J Neurochem. 2008; 106:1594-1603.
63. Zou ZD, Liu N, Guo P, Guo LY, Sun Y, Shi J, Wang L. Analysis on clinical treatment in hypertension by traditional Chinese medicine for 10 years in Beijing. Zhongguo Zhong Yao Za Zhi. 2007; 32:1569-1572. (in Chinese)
64. Cao Y, Zhang X, Fang Y, Ye J. Determination of the active ingredients in Gastrodia rhizoma by capillary electrophoresis with electrochemical detection. Analyst. 2001; 126:1524-1528.
65. Ojemann LM, Nelson WL, Shin DS, Rowe AO, Buchanan RA. Tianma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy Behav. 2006; 8:376-383.
66. Liu Y, Tang X, Pei J, Zhang L, Liu F, Li K. Gastrodin interaction with human fibrinogen: Anticoagulant effects and binding studies. Chemistry. 2006; 12:7807-7815.
67. Liu ZH, Hu HT, Feng GF, Zhao ZY, Mao NY. Protective effects of gastrodin on the cellular model of Alzheimer's disease induced by Abeta25-35. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005; 36:537-540. (in Chinese)
68. Citron M. Alzheimer's disease: Strategies for disease modification. Nat Rev Drug Discov. 2010; 9:387-398.
69. Sa Q, Wang Y, Li W, Zhang L, Sun Y. The promoter of an antifungal protein gene from Gastrodia elata confers tissue-specific and fungus-inducible expression patterns and responds to both salicylic acid and jasmonic acid. Plant Cell Rep. 2003; 22:79-84.
70. Liu W, Hu YL, Wang M, Xiang Y, Hu Z, Wang DC. Purification, crystallization and preliminary X-ray diffraction analysis of a novel mannose-binding lectin from Gastrodia elata with antifungal properties. Acta Crystallogr D Biol Crystallogr. 2002; 58:1833-1835.